TPSF
PCRX icon

Texas Permanent School Fund’s Pacira BioSciences PCRX Stock Holding History

Texas Permanent School Fund’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,642
Closed -$1.19M – 1019
2024
Q1 		$1.19M Buy
40,642
+543
+1% +$16.7K 0.01% 1267
2023
Q4 		$1.35M Buy
40,099
+695
+2% +$20.3K 0.01% 1212
2023
Q3 		$1.21M Sell
39,404
-948
-2% -$34.2K 0.01% 1172
2023
Q2 		$1.62M Sell
40,352
-672
-2% -$27.8K 0.02% 1083
2023
Q1 		$1.67M Buy
41,024
+10,178
+33% +$405K 0.02% 1042
2022
Q4 		$1.19M Sell
30,846
-2,113
-6% -$103K 0.02% 1036
2022
Q3 		$1.75M Buy
32,959
+118
+0.4% +$6.56K 0.03% 824
2022
Q2 		$1.92M Buy
32,841
+1,261
+4% +$82.6K 0.03% 788
2022
Q1 		$2.41M Sell
31,580
-535
-2% -$35.7K 0.03% 733
2021
Q4 		$1.93M Sell
32,115
-770
-2% -$42.5K 0.02% 930
2021
Q3 		$1.84M Buy
32,885
+76
+0.2% +$4.38K 0.02% 940
2021
Q2 		$1.99M Buy
32,809
+39
+0.1% +$2.47K 0.02% 921
2021
Q1 		$2.3M Sell
32,770
-2,113
-6% -$151K 0.03% 820
2020
Q4 		$2.09M Sell
34,883
-5,042
-13% -$295K 0.03% 822
2020
Q3 		$2.4M Buy
39,925
+6,646
+20% +$386K 0.03% 668
2020
Q2 		$1.75M Sell
33,279
-2,217
-6% -$92.7K 0.03% 765
2020
Q1 		$1.19M Buy
35,496
+6,952
+24% +$289K 0.02% 865
2019
Q4 		$1.29M Buy
28,544
+205
+0.7% +$8.71K 0.02% 977
2019
Q3 		$1.08M Buy
+28,339
New +$1.13M 0.02% 1032

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Texas Permanent School Fund's PCRX Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Pacira BioSciences (PCRX) in Q2 2024, closing a stake of 40,642 shares — an estimated $1.19M sold.

Texas Permanent School Fund first reported a position in PCRX in Q3 2019 and held it in 19 quarters. The position peaked at $2.41M in Q1 2022. 280 funds tracked by Wall St. Rank hold PCRX as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Pacira BioSciences position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 40,642 Pacira BioSciences shares in Q2 2024, an estimated $1.19M.
  • Texas Permanent School Fund first reported a position in Pacira BioSciences in Q3 2019 and held it in 19 quarters.
  • Texas Permanent School Fund's Pacira BioSciences position peaked at $2.41M in Q1 2022.
  • 280 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.